An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain
Kenji Onouchi,1 Hiroaki Koga,2 Kazumasa Yokoyama,3 Tamotsu Yoshiyama4 1Aida Memorial Rehabilitation Hospital, Moriya, Japan; 2Kumamoto Rehabilitation Hospital, Kikuchi-Gun, Japan; 3Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; 4Pfizer Japan Inc., Tokyo, Japan Purpo...
Main Authors: | Onouchi K, Koga H, Yokoyama K, Yoshiyama T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Journal of Pain Research |
Online Access: | http://www.dovepress.com/an-open-label-long-term-study-examining-the-safety-and-tolerability-of-peer-reviewed-article-JPR |
Similar Items
-
The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
by: Parsons B, et al.
Published: (2019-03-01) -
Clinical use of pregabalin in the management of central neuropathic pain
by: Nanna B Finnerup, et al.
Published: (2007-01-01) -
Duloxetine and pregabalin in neuropathic pain of lung cancer patients
by: Şule Karabulut Gül, et al.
Published: (2020-03-01) -
Pregabalin and other antiepileptic drugs in chronic neuropathic pain
by: Paolo Marchettini
Published: (2017-05-01) -
Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
by: Martinez Jose A, et al.
Published: (2012-01-01)